BILL HOLDINGS INC (BILL) Fundamental Analysis & Valuation

NYSE:BILL • US0900431000

Current stock price

39.78 USD
+0.15 (+0.38%)
At close:
39.78 USD
0 (0%)
After Hours:

This BILL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BILL Profitability Analysis

1.1 Basic Checks

  • BILL had positive earnings in the past year.
  • In the past year BILL had a positive cash flow from operations.
  • BILL had negative earnings in 4 of the past 5 years.
  • BILL had a positive operating cash flow in 4 of the past 5 years.
BILL Yearly Net Income VS EBIT VS OCF VS FCFBILL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • The Return On Assets of BILL (-0.24%) is comparable to the rest of the industry.
  • BILL's Return On Equity of -0.64% is in line compared to the rest of the industry. BILL outperforms 59.19% of its industry peers.
Industry RankSector Rank
ROA -0.24%
ROE -0.64%
ROIC N/A
ROA(3y)-0.8%
ROA(5y)-1.52%
ROE(3y)-1.86%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
BILL Yearly ROA, ROE, ROICBILL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

1.3 Margins

  • BILL's Gross Margin of 80.58% is amongst the best of the industry. BILL outperforms 82.72% of its industry peers.
  • In the last couple of years the Gross Margin of BILL has grown nicely.
  • The Profit Margin and Operating Margin are not available for BILL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y1.61%
BILL Yearly Profit, Operating, Gross MarginsBILL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

3

2. BILL Health Analysis

2.1 Basic Checks

  • BILL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BILL has been reduced compared to 1 year ago.
  • The number of shares outstanding for BILL has been increased compared to 5 years ago.
  • BILL has a worse debt/assets ratio than last year.
BILL Yearly Shares OutstandingBILL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BILL Yearly Total Debt VS Total AssetsBILL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • BILL has an Altman-Z score of 0.60. This is a bad value and indicates that BILL is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BILL (0.60) is worse than 67.28% of its industry peers.
  • The Debt to FCF ratio of BILL is 5.52, which is a neutral value as it means it would take BILL, 5.52 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.52, BILL is in line with its industry, outperforming 54.41% of the companies in the same industry.
  • A Debt/Equity ratio of 0.48 indicates that BILL is not too dependend on debt financing.
  • BILL has a worse Debt to Equity ratio (0.48) than 64.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.52
Altman-Z 0.6
ROIC/WACCN/A
WACC9.39%
BILL Yearly LT Debt VS Equity VS FCFBILL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.65 indicates that BILL should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.65, BILL perfoms like the industry average, outperforming 50.37% of the companies in the same industry.
  • A Quick Ratio of 1.65 indicates that BILL should not have too much problems paying its short term obligations.
  • BILL has a Quick ratio (1.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
BILL Yearly Current Assets VS Current LiabilitesBILL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. BILL Growth Analysis

3.1 Past

  • The earnings per share for BILL have decreased by -3.39% in the last year.
  • The Revenue has grown by 11.84% in the past year. This is quite good.
  • Measured over the past years, BILL shows a very strong growth in Revenue. The Revenue has been growing by 56.14% on average per year.
EPS 1Y (TTM)-3.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y31.58%
Revenue growth 5Y56.14%
Sales Q2Q%14.37%

3.2 Future

  • Based on estimates for the next years, BILL will show a very strong growth in Earnings Per Share. The EPS will grow by 23.69% on average per year.
  • BILL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.60% yearly.
EPS Next Y9.69%
EPS Next 2Y10.91%
EPS Next 3Y13.03%
EPS Next 5Y23.69%
Revenue Next Year12.53%
Revenue Next 2Y13.18%
Revenue Next 3Y13.54%
Revenue Next 5Y16.6%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BILL Yearly Revenue VS EstimatesBILL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BILL Yearly EPS VS EstimatesBILL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

5

4. BILL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.45 indicates a rather expensive valuation of BILL.
  • Compared to the rest of the industry, the Price/Earnings ratio of BILL indicates a somewhat cheap valuation: BILL is cheaper than 75.74% of the companies listed in the same industry.
  • BILL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.95.
  • A Price/Forward Earnings ratio of 14.57 indicates a correct valuation of BILL.
  • BILL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BILL is cheaper than 76.47% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.68, BILL is valued rather cheaply.
Industry RankSector Rank
PE 17.45
Fwd PE 14.57
BILL Price Earnings VS Forward Price EarningsBILL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BILL is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, BILL is valued cheaply inside the industry as 87.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.84
EV/EBITDA 109.94
BILL Per share dataBILL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BILL does not grow enough to justify the current Price/Earnings ratio.
  • BILL's earnings are expected to grow with 13.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.8
PEG (5Y)N/A
EPS Next 2Y10.91%
EPS Next 3Y13.03%

0

5. BILL Dividend Analysis

5.1 Amount

  • No dividends for BILL!.
Industry RankSector Rank
Dividend Yield 0%

BILL Fundamentals: All Metrics, Ratios and Statistics

BILL HOLDINGS INC

NYSE:BILL (4/21/2026, 4:54:39 PM)

After market: 39.78 0 (0%)

39.78

+0.15 (+0.38%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners111.86%
Inst Owner Change-0.05%
Ins Owners12.07%
Ins Owner Change15.71%
Market Cap3.94B
Revenue(TTM)1.55B
Net Income(TTM)-24.21M
Analysts78.06
Price Target58.55 (47.18%)
Short Float %14.91%
Short Ratio4.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.92%
Min EPS beat(2)12.65%
Max EPS beat(2)17.2%
EPS beat(4)4
Avg EPS beat(4)21.98%
Min EPS beat(4)12.65%
Max EPS beat(4)30.07%
EPS beat(8)8
Avg EPS beat(8)20.17%
EPS beat(12)12
Avg EPS beat(12)30.61%
EPS beat(16)16
Avg EPS beat(16)52.39%
Revenue beat(2)1
Avg Revenue beat(2)0.63%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)2.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)2.05%
Revenue beat(8)4
Avg Revenue beat(8)0.69%
Revenue beat(12)8
Avg Revenue beat(12)1.82%
Revenue beat(16)12
Avg Revenue beat(16)2.77%
PT rev (1m)-0.53%
PT rev (3m)-7.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.56%
EPS NY rev (1m)0%
EPS NY rev (3m)7.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE 17.45
Fwd PE 14.57
P/S 2.54
P/FCF 11.84
P/OCF 10.21
P/B 1.03
P/tB 3.23
EV/EBITDA 109.94
EPS(TTM)2.28
EY5.73%
EPS(NY)2.73
Fwd EY6.87%
FCF(TTM)3.36
FCFY8.44%
OCF(TTM)3.9
OCFY9.79%
SpS15.68
BVpS38.47
TBVpS12.31
PEG (NY)1.8
PEG (5Y)N/A
Graham Number44.4232 (11.67%)
Profitability
Industry RankSector Rank
ROA -0.24%
ROE -0.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.58%
FCFM 21.42%
ROA(3y)-0.8%
ROA(5y)-1.52%
ROE(3y)-1.86%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y1.61%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.52
Debt/EBITDA 85.17
Cap/Depr 51.96%
Cap/Sales 3.42%
Interest Coverage N/A
Cash Conversion 1790.69%
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 0.6
F-Score4
WACC9.39%
ROIC/WACCN/A
Cap/Depr(3y)32.89%
Cap/Depr(5y)61.93%
Cap/Sales(3y)2.46%
Cap/Sales(5y)3.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y9.69%
EPS Next 2Y10.91%
EPS Next 3Y13.03%
EPS Next 5Y23.69%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y31.58%
Revenue growth 5Y56.14%
Sales Q2Q%14.37%
Revenue Next Year12.53%
Revenue Next 2Y13.18%
Revenue Next 3Y13.54%
Revenue Next 5Y16.6%
EBIT growth 1Y-5.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.02%
EBIT Next 3Y26.29%
EBIT Next 5Y37.8%
FCF growth 1Y52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.62%
OCF growth 3YN/A
OCF growth 5YN/A

BILL HOLDINGS INC / BILL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BILL HOLDINGS INC (BILL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BILL.


Can you provide the valuation status for BILL HOLDINGS INC?

ChartMill assigns a valuation rating of 5 / 10 to BILL HOLDINGS INC (BILL). This can be considered as Fairly Valued.


What is the profitability of BILL stock?

BILL HOLDINGS INC (BILL) has a profitability rating of 3 / 10.


How financially healthy is BILL HOLDINGS INC?

The financial health rating of BILL HOLDINGS INC (BILL) is 3 / 10.